Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
This trial update reports on PET/CT imaging protocol optimization using optimized F18-FDG dosing to minimize radiation exposure while improv…
-
CLINICAL_TRIALS research · 2017-11-20Clinical Trial Update: Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
This clinical trial update describes a consent process change allowing collection of additional tissue during diagnostic biopsy in lymphoma …
-
FDA approval · 2017-11-03FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for doxorubicin hydrochloride from BluePoint Laboratories, adding a new approved generic version of …
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma [NA]
Clinical trial evaluating induction chemotherapy with ABVD followed by brentuximab vedotin consolidation in newly diagnosed, non-bulky stage…
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of iodine-131–labeled monoclonal antibody BC8 used before autologous stem cell transplant in relapsed or refractory Hodgkin ly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating brentuximab vedotin plus AVD in limited-stage Hodgkin lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating chemotherapy followed by unrelated donor stem cell transplantation for blood and immune system cancers; …
-
CLINICAL_TRIALS research · 2017-08-10Clinical Trial Update: Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation [Phase 2]
A Phase 2 trial is evaluating low-dose plerixafor plus G-CSF to mobilize stem cells for autologous peripheral blood transplantation in lymph…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies [Phase 2]
This Phase 2 randomized trial comparing haplo cord blood transplantation versus double umbilical cord blood transplantation for hematologic …
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic [NA]
This clinical trial update reports on cytokine kinetics and prognostic indicators in Hodgkin lymphoma, with the study status listed as compl…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Preservation of Ovarian Function After Hematopoietic Cell Transplant [Phase 2]
Phase 2 trial investigating preservation of ovarian function after hematopoietic cell transplantation in patients with hematologic cancers; …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
A completed multi-institutional NIH study evaluated late treatment effects in long-term survivors of Hodgkin lymphoma, investigating long-te…
-
CLINICAL_TRIALS withdrawal · 2017-06-27Clinical Trial Update: Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) [Phase 1, Phase 2]
The Phase 1/2 trial assessing pembrolizumab in combination with chemotherapy for advanced lymphoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248) [Phase 1]
Phase 1 dose-escalation study of MK-8776 (SCH 900776) with and without gemcitabine in solid tumors or lymphoma completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease [Phase 2]
This Phase 2 trial evaluated gemcitabine-based chemotherapy followed by peripheral blood stem cell rescue for Hodgkin lymphoma. Results were…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study evaluating plerixafor (AMD3100) as a stem cell mobilizer for transplantation from a sibling donor in various hematologic mal…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT [Phase 2]
Phase 2 trial of sirolimus and mycophenolate mofetil as graft-versus-host disease prophylaxis in myeloablative, matched related donor hemato…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy and radiation therapy in young patients with newly diagnosed Hodgkin Lymphoma; results pos…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen with alemtuzumab, fludarabine phosphate, and total-body irradiation followed by cyclosporine…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating bendamustine hydrochloride, rituximab, etoposide, and carboplatin in relapsed/refractory diffuse large B-cell lym…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma [Phase 1, Phase 2]
Clinical trial investigating Yttrium-90-labeled daclizumab with chemotherapy and stem cell transplant in Hodgkin lymphoma has terminated; re…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma [Phase 2]
Phase 2 study evaluating the combination of bendamustine hydrochloride, etoposide, dexamethasone, and filgrastim for peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating cyclophosphamide as GVHD prophylaxis after allogeneic peripheral blood stem cell transplantation in patients with h…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial
Biomarker analyses in tissue samples from patients with Hodgkin lymphoma enrolled in the ECOG-ACRIN ECOG-2496 trial; the study has completed…